Glen Eagle Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.77M | Buy |
|
|||||
|
2025
Q2 | $2.83M | Sell |
|
|||||
|
2025
Q1 | $3M | Buy |
|
|||||
|
2024
Q4 | $2.7M | Buy |
|
|||||
|
2024
Q3 | $3.08M | Buy |
|
|||||
|
2024
Q2 | $3.1M | Buy |
|
|||||
|
2024
Q1 | $2.53M | Buy |
|
|||||
|
2023
Q4 | $1.77M | Sell |
|
|||||
|
2023
Q3 | $1.72M | Sell |
|
|||||
|
2023
Q2 | $2.06M | Buy |
|
|||||
|
2023
Q1 | $1.48M | Buy |
|
|||||
|
2022
Q4 | $1.26M | Buy |
|
|||||
|
2022
Q3 | $713K | Buy |
|
|||||
|
2022
Q2 | $314K | Buy |
|
|||||
|
2022
Q1 | $261K | Sell |
|
|||||
|
2021
Q4 | $254K | Sell |
|
|||||
|
2021
Q3 | $227K | Buy |
|
|||||
|
2021
Q2 | $201K | Hold |
|
|||||
|
2021
Q1 | $163K | Buy |
|
|||||
|
2020
Q4 | $137K | Buy |
|
|||||
|
2020
Q3 | $118K | Sell |
|
|||||
|
2020
Q2 | $133K | Buy |
|
|||||
|
2020
Q1 | $112K | Buy |
|
|||||
|
2019
Q4 | $103K | Buy |
|
|||||
|
2019
Q3 | $78.3K | Hold |
|
|||||
|
2019
Q2 | $77.6K | Buy |
|
|||||
|
2019
Q1 | $78.5K | Hold |
|
|||||
|
2018
Q4 | $70K | Hold |
|
|||||
|
2018
Q3 | $64.9K | Sell |
|
|||||
|
2018
Q2 | $60.2K | Hold |
|
|||||
|
2018
Q1 | $54.5K | Sell |
|
|||||
|
2017
Q4 | $61K | Hold |
|
|||||
|
2017
Q3 | $61.8K | Hold |
|
|||||
|
2017
Q2 | $59.4K | Hold |
|
|||||
|
2017
Q1 | $60.7K | Sell |
|
|||||
|
2016
Q4 | $74.5K | Buy |
|